
Sign up to save your podcasts
Or
Enterococci, particularly vancomycin-resistant isolates tend to affect the most vulnerable and immunocompromised patients and are one of the most difficult bacteria to treat. In absence of robust clinical data, we will discuss therapeutic approaches for these recalcitrant organism.
4.6
2424 ratings
Enterococci, particularly vancomycin-resistant isolates tend to affect the most vulnerable and immunocompromised patients and are one of the most difficult bacteria to treat. In absence of robust clinical data, we will discuss therapeutic approaches for these recalcitrant organism.
28 Listeners
36 Listeners
2,053 Listeners
12 Listeners
452 Listeners
20 Listeners
4 Listeners
4 Listeners
325 Listeners
511 Listeners
496 Listeners
3,336 Listeners
1,095 Listeners
272 Listeners
194 Listeners
519 Listeners
349 Listeners
160 Listeners
189 Listeners
36 Listeners
82 Listeners
3 Listeners